Stocks · Healthcare · Medical - Care Facilities
Astrana Health, Inc. ASTH
$35.88 +2.78% Close, Oct 2, 2026 · NASDAQ · Market cap $1.78B
Strong growthInexpensive vs sector
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $3.84B, up 58.9% from a year earlier, accelerating from 56.7% a quarter earlier.
- Diluted EPS over the last four quarters was $0.82, up 57.2% year over year.
- Net debt is 3.3× EBITDA, a high level of leverage.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 14%
- EPS growth (TTM, YoY)Top 24%
- FCF growth (TTM, YoY)Top 38%
- Revenue growth, 3-year CAGRTop 16%
- Revenue growth accelerationTop 26%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 26%
- Gross marginBottom 9%
- Operating marginTop 38%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Bottom 46%
- Net debt / EBITDA (lower is better)Bottom 27%
- Interest coverTop 39%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 23%
- Free-cash-flow yieldTop 9%
- EBITDA / enterprise valueTop 15%
- Sales / enterprise valueTop 6%
- P/E vs own 5-year history (lower is better)Bottom 18%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 40%
- 6-month returnTop 22%
- 1-year return vs S&P 500Top 38%
- Distance from 52-week highTop 47%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 20%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetBottom 42%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 45%
- Maximum drawdown, 3 yearsBottom 49%
- Beta vs S&P 500 (lower is better)Top 47%
- Net debt / EBITDA (lower is better)Bottom 27%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 56.7% | 58.9% | ↑ |
| EPS growth (YoY) | -16.8% | 57.2% | ↑ |
| Gross margin | 11.8% | 9.2% | ↓ |
| Operating margin | 2.9% | 2.6% | ↓ |
| FCF margin | 5.0% | 4.1% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 58.9% | 56.7% | ↑ | Top 14% |
| EPS growth (TTM, YoY) | 57.2% | -16.8% | ↑ | Top 24% |
| Gross margin | 9.2% | 11.8% | ↓ | Bottom 9% |
| Operating margin | 2.6% | 2.9% | ↓ | Top 38% |
| Net margin | 1.1% | 1.0% | ↑ | — |
| Free-cash-flow margin | 4.1% | 5.0% | ↓ | — |
| Return on invested capital | 4.1% | — | Top 26% | |
| Revenue growth, 3-year CAGR | 40.6% | — | Top 16% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -24.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 3.31×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 1.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.11%
- Net buyback yield (TTM)
- 1.30%
- Shareholder yield
- 1.41%
- Share count change, 1 year
- +0.6%
- Share count change, 3-year CAGR
- +2.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -23.8%
- Average 2-day reaction, last 8
- +3.5%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $52.00
- Target vs current price
- +44.9%
- Analysts with a rating
- 11
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +19.1% | -4.7% | -0.1% | +7.6% | — |
| May 7, 2026 | +3.4% | +2.4% | +12.8% | +7.4% | +1.9% |
| Mar 2, 2026 | -20.0% | +29.5% | +22.5% | +19.0% | +89.6% |
| Nov 6, 2025 | -97.9% | +0.4% | -29.1% | -31.4% | -36.0% |
| Aug 7, 2025 | -47.2% | -1.6% | +35.9% | +41.3% | +45.9% |
| May 8, 2025 | -39.1% | +4.0% | -17.5% | -22.8% | -31.9% |
| Feb 27, 2025 | -168.2% | -1.2% | -22.5% | -12.3% | -30.3% |
| Nov 7, 2024 | +3.1% | -0.7% | -29.6% | -27.9% | -38.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.40 | $0.34 | +19.1% | $972.5M |
| May 7, 2026 | $0.30 | $0.29 | +3.4% | $965.1M |
| Mar 2, 2026 | $0.12 | $0.15 | -20.0% | $950.5M |
| Nov 6, 2025 | $0.01 | $0.47 | -97.9% | $956.0M |
| Aug 7, 2025 | $0.19 | $0.36 | -47.2% | $654.8M |
| May 8, 2025 | $0.14 | $0.23 | -39.1% | $620.4M |
| Feb 27, 2025 | -$0.15 | $0.22 | -168.2% | $665.2M |
| Nov 7, 2024 | $0.33 | $0.32 | +3.1% | $478.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 43.9× | 32.8× | 78th | Top 23% |
| P/E (forward) | 25.7× | — | — | — |
| EV / EBITDA | 13.5× | — | — | Top 15% |
| EV / Sales | 0.61× | — | — | Top 6% |
| Free-cash-flow yield | 8.91% | — | — | Top 9% |
| Earnings yield | 2.28% | — | — | Top 23% |
P/E over the past five years
Range 24.1× – 113.6× since Mar 31, 2022. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +27.4%
- Earnings per share growth (TTM)
- +57.2%
- Change in P/E multiple
- +11.0%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 126
- 50-day average slope (20 days)
- -9.4%
- 200-day average slope (20 days)
- +4.5%
- Distance from 50-day average
- -3.3%
- Distance from 200-day average
- +9.8%
- RSI (14)
- 47.3
- Relative volume
- 0.74×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 52.9%
- Volatility vs own 5-year history
- 46th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.07
- Correlation with S&P 500
- 0.25
- Current drawdown from 1-year high
- -28.0%
- Maximum drawdown, 3 years
- -71.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 16, 2021 | Feb 12, 2026 | -84.8% | 1063 days | Not yet recovered |
| Jul 23, 2021 | Oct 29, 2021 | -39.2% | 69 days | 11 days (Nov 15, 2021) |
| Jul 12, 2021 | Jul 16, 2021 | -15.0% | 4 days | 3 days (Jul 21, 2021) |
| May 10, 2021 | May 14, 2021 | -10.7% | 4 days | 6 days (May 24, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.78B
- P/E (TTM)
- 43.9
- EPS, diluted (TTM)
- $0.82
- Revenue (TTM)
- $3.84B
- 52-week range
- $18.08 – $51.60
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $773.9M | $1.14B | $1.39B | $2.03B | $3.18B |
| Gross profit | $177.8M | $199.5M | $215.0M | $271.4M | $295.8M |
| Operating income | $98.2M | $104.3M | $84.6M | $89.3M | $78.5M |
| Net income | $68.9M | $45.2M | $60.7M | $43.1M | $22.5M |
| EPS (diluted) | $1.52 | $0.99 | $1.29 | $0.90 | $0.46 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $478.7M | $665.2M | $620.4M | $654.8M | $956.0M | $950.5M | $965.1M | $972.5M |
| Net income | $16.1M | -$7.0M | $6.7M | $9.4M | $373,000 | $6.0M | $14.4M | $19.7M |
| EPS (diluted) | $0.33 | -$0.14 | $0.14 | $0.19 | $0.01 | $0.12 | $0.29 | $0.40 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $70.3M | $82.1M | $68.2M | $52.2M | $114.6M |
| Capital expenditure | -$19.2M | -$22.9M | -$28.5M | -$8.0M | -$10.1M |
| Free cash flow | $51.1M | $59.2M | $39.7M | $44.2M | $104.5M |
| Dividends paid | -$31.1M | -$14.0M | -$62.1M | -$4.0M | -$7.9M |
| Net share buybacks | $34.4M | -$9.3M | -$10.2M | -$937,000 | -$15.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $400.8M
- Total assets
- $2.28B
- Total liabilities
- $1.68B
- Total debt
- $979.4M
- Net debt
- $578.6M
- Shareholders’ equity
- $830.2M
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 3,273,033
- Days to cover
- 11.71
- Change vs previous report
- -0.3%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Apr 27, 2015
- 1-for-10
- Nov 26, 2007
- 1-for-136
- Jul 23, 2007
- 1-for-136